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In this first issue of the Netherlands Heart Journal in 2017,
I would like to introduce to you a new editorial board, con-
sisting of an editor-in-chief and five deputy editors. It is an
Amsterdam-based editorial board to facilitate close interac-
tion between the board members. It is the ambition of the
new editorial board to further improve the journal’s current
impact factor as an index of its quality and success. The
attractiveness of the journal for authors may be enhanced
by offering a rapid review system, which requires close
collaboration between the associate editors and the national
editorial and international advisory board. Moreover, the
Netherlands Heart Journal is an open access, peer review
journal offering services without payment for authors in
contrast with numerous other open access journals.
Professor Jan J. Piek (Fig. 1) completed his residency
program in cardiology at the Academic Medical Center
of the University of Amsterdam (1984–1989), followed by
a subspecialisation in interventional cardiology. He finished
his thesis on the coronary collateral circulation in 1992.
He was appointed as Professor of Clinical Cardiology in
1999. He has been co-chairman of the Department of Car-
diology since 2004 and he was appointed director of the
AMC Heart Center in 2008. The interests of the research
group of Professor Piek include coronary haemodynamics,
the inflammatory response in acute myocardial infarction
and atherosclerosis, and the formation of coronary collat-
eral circulation.
Yigal Pinto (Fig. 2) was trained as a cardiologist in
Groningen in the Netherlands (1995–2001), and worked
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as a staff cardiologist at the University Hospital Maastricht
(2001–2008) before moving to the AMC. He received basic
research training in Boston (in the group of Victor J. Dzau)
and in Berlin (in the group of Martin Paul).
The main research interest of the Pinto group (AMC,
Amsterdam) is to identify novel mechanisms that can help
treat or diagnose cardiomyopathies, such as genetic forms
of DCM. His group focuses on RNA biology in relation to
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genetic variants that are related to heart failure and trans-
lates findings to biomarkers or therapeutic targets.
Robbert de Winter (Fig. 3) studied biophysics in Leiden
(1976–1980, MSc: 1987) and medicine in Amsterdam
(1980–1988). He was trained as a cardiologist (1988–1994)
and interventional cardiologist (1994–1995) in Amsterdam.
He has been a staff member of the AMC since 1994 and
Professor of Clinical Cardiology since 2008.
The main research interest of his research group re-
lates to acute coronary syndromes, diagnostics, risk pre-
diction and outcome in STEMI and NSTEMI patients and
biomarker studies. In addition, there is increased involve-
ment in structural and congenital heart disease both in per-
cutaneous procedures and in research projects.
Ron Peters (Fig. 4) had all of his training at the Uni-
versity of Amsterdam: medical school, specialty certifica-
tion in internal medicine and cardiology, PhD studies on
intracoronary ultrasound imaging, and his appointment as
Professor of Clinical Cardiology. His research topic is pre-
vention of coronary artery disease.
Joris de Groot (Fig. 5) was born and raised in Amster-
dam, the Netherlands. He studied medicine at the Univer-
sity of Amsterdam (MD 1997, cum laude), and defended
his PhD thesis at that same institution in 2001. He was
a research fellow with Michael R. Rosen MD (Columbia
University, New York, NY) and with José Jalife (SUNY
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Upstate Medical University, Syracuse, NY). After his train-
ing as a cardiologist (2008) he subspecialised as a clinical
electrophysiologist (2010), both at the AMC. The research
interests of his group consist of mechanisms and treatment
of atrial fibrillation, closely intertwined with the thoraco-
scopic atrial fibrillation ablation program and the Labora-
tory of Experimental Cardiology. Furthermore, his group
publishes on arrhythmias in adult congenital heart disease.
Jolanda van der Velden (Fig. 6) studied medical biol-
ogy at the University of Leiden, and received a PhD in
Physiology (1998) at the VU University in Amsterdam. In
2013 she became Professor of the Netherlands Heart Insti-
tute (Utrecht), and since 2014 she is chair of the Depart-
ment of Physiology at the VU University Medical Center
in Amsterdam. The main research interest of the Van der
Velden group is to understand the role of cellular proteins
in cardiac muscle cell dysfunction during the development
of heart failure. In vitro studies at the cellular level are
combined with in vivo imaging studies of cardiac function
in patients. Currently, novel compounds are being tested in
cardiac tissue systems and animal models aimed to prevent
cardiac dysfunction.
The editorial board would like to take the opportunity
to thank the previous board members and in particular Pro-
fessor E.E. van der Wall, who served as editor-in-chief for
almost three decades, initially as the editor-in-chief of the
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Nederlands Tijdschrift voor Cardiologie followed by the
journal Cardiologie and finally the Netherlands Heart Jour-
nal. These efforts led to the current position of the Nether-
lands Heart Journal among the top of the 60 national society
journals of the ESC-related countries. The editorial board
acknowledges the support of the Netherlands Society of
Cardiology in its endeavour to further improve the quality
of the Netherlands Heart Journal.
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